Magazine article from our research archive:
|
|
30th Annual San Antonio Breast Cancer Symposium.(Conference Report)
- Article from:
-
Advances in Breast Cancer
- Article date:
-
March 1, 2008
- Author:
-
|
Copyright informationCOPYRIGHT 2008 Mediscript Ltd. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Introduction
Over 8000 healthcare professionals involved in the treatment of breast cancer attended the international San Antonio Breast Cancer Symposium (SABCS) from 13-16 December 2007. At the opening address, Kent Osbourne outlined the future direction of breast cancer care including the 'personalisation' of cancer treatment with the use of genetics and genetic profiling for prognosis and prediction, targeted therapy and molecular mechanisms of resistance. Over 4 days, many aspects of breast cancer were highlighted, from diagnosis, to therapeutic management and survivorship issues.
Chemotherapy in early breast cancer
The benefit of adjuvant chemotherapy in ...
<18; P=0.97) compared to a subgroup who gained strong benefit (high RS><1 cm), no lymphovascular invasion and only a single positive sentinel lymph node out of multiple sentinel nodes (>
Related newspaper, magazine, and journal articles:
|
President and Founder of LIVING BEYOND BREAST CANCER Lauds Approval of...
PR Newswire;
October 30, 1998 ;
328 words
......of NOLVADEX(R) for the Reduction of Breast Cancer in Women at High Risk PHILADELPHIA...approved tamoxifen for the reduction of breast cancer in women at high risk, Marisa C. Weiss...president and founder of Living Beyond Breast Cancer, noted that, The FDA's decision brings...
|
|
Landmark Findings from Breast Cancer Prevention Trial Lead FDA to Approve...
PR Newswire;
October 29, 1998 ;
700+ words
......Approved to Reduce the Incidence of Breast Cancer WILMINGTON, Del., Oct. 29 /PRNewswire...Administration (FDA) has approved its breast cancer drug NOLVADEX(R) (tamoxifen citrate) for the reduction in the incidence of breast cancer in women at high risk for developing...
|
|
Susan G. Komen for the Cure(R)'s New 'Imagine' Campaign Ties Public to Its...
PR Newswire;
August 8, 2008 ;
700+ words
......challenged to imagine life without breast cancer in a new promotional campaign launching...the Cure(R), the global leader in the breast cancer movement. (Logo: http://www.newscom...with Komen's vision of a world without breast cancer. The campaign is prominently featured...
|
|
Research and Markets : Analysis of new R&D strategies for Breast Cancer.
M2 Presswire;
April 6, 2005 ;
609 words
......Analysis of new R&D strategies for Breast Cancer(C)1994-2005 M2 COMMUNICATIONS LTD RDATE...c15292) has announced the addition of Breast Cancer: The Latest R&D Trends to their...mid stage to late stage drugs with breast cancer therapy strategies. This extensive...
|
|
Twenty-Five Individuals Honored by Yoplait(R) for Making Extraordinary...
PR Newswire;
March 18, 2008 ;
700+ words
......as the Yoplait Champions Grow to 100 Breast Cancer Advocates Across the Country MINNEAPOLIS...communities to help in the fight against breast cancer. For the fourth time, these organizations...courage, strength and dedication to the breast cancer cause. (Photo: ...
|
|
Celera and LabCorp(R) Announce Licensing Agreement to Commercialize Breast...
PR Newswire;
April 25, 2007 ;
700+ words
......granting LabCorp a license to Celera's breast cancer metastasis and estrogen/progesterone...the risk of metastasis in early stage breast cancer patients, and a second test to provide...LabCorp. Applying Celera's findings in breast cancer to the development of new tests supports...
|
|
Susan G. Komen for the Cure(R) Calls on Policymakers to Address Unfairness...
PR Newswire;
April 11, 2008 ;
700+ words
......Campaign to Close the Gaps that Make Breast Cancer Deadlier for Low-Income Women and Women...PRNewswire/ -- Today, more than 100 breast cancer survivors and advocates from the Massachusetts...Massachusetts women will be diagnosed with breast cancer and nearly 900 will die. At a ...
|
|
Susan G. Komen for the Cure(R) Comments on Christina Applegate's Breast...
PR Newswire;
August 6, 2008 ;
570 words
......Applegate as she undergoes treatment for breast cancer. (Logo: http://www.newscom.com/cgi...over the years. As the daughter of a breast cancer survivor, she has been active in encouraging people to remain vigilant about breast cancer screening. We were comforted to hear...
|
|
Research and Markets: Analysis of New R&D Strategies for Breast Cancer.
PR Newswire;
April 6, 2005 ;
640 words
......c15294) has announced the addition of Breast Cancer: The Latest R&D Trends to their...mid stage to late stage drugs with breast cancer therapy strategies. This extensive...anti-cancer drugs in development for breast cancer treatment. We also view the competitive...
|
|
Lowe's Plant for the Cure(R) Supports Fight Against Breast Cancer.
PR Newswire;
April 26, 2006 ;
568 words
......Raise Dollars for the Fight Against Breast Cancer MOORESVILLE, N.C., April 26 /PRNewswire...Continuing its support of the fight against breast cancer, Lowe's Companies, Inc. will sell eight-in...price will benefit the Susan G. Komen Breast Cancer Foundation. (Logo: ...
|
|
Chicago Area Residents to Again Join Fight Against Breast Cancer in The...
PR Newswire;
September 14, 2000 ;
537 words
......Chicago area fourth annual Susan G. Komen Breast Cancer Foundation Race for the Cure(R) 5K...walking shoes to help raise money for breast cancer research, education, screening and...awareness to this important cause, said breast cancer survivor and Honorary Chair Denise...
|
|
Schering-Plough Announces EU Approval of CAELYX(R) in Metastatic Breast...
PR Newswire;
January 14, 2003 ;
700+ words
......hydrochloride) as monotherapy for metastatic breast cancer in patients who are at increased cardiac...mucocutaneous or visceral disease. In the breast cancer clinical registration program, CAELYX...active agents used to treat metastatic breast cancer. Additionally, CAELYX was found ...
|
See all results.
Or, try our
Advanced Search.
|